Evidence map›Paper›PMID 34046650›Full record

ArticleJournal of neuroscience & cognitive studies2020

Replicated risk

Xiaoyun Guo, Yingmei Fu, Yong Zhang, Tong Wang, Lu Lu, Xingqun Luo, Kesheng Wang, Juncao Huang, Ting Xie, Chengchou Zheng and 8 more

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Journal of neuroscience & cognitive studies, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. L-methionine and the L-type CaFrontiers in neural circuits · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Xiaoyun GuoShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Yingmei FuShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Yong ZhangTianjin Mental Health Center, Tianjin 300222, China.
Tong WangCellular &Molecular Physiology, Yale University School of Medicine, New Haven, CT 06510, USA.
Lu LuDepartments of Genetics, Genomics, Informatics, Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Xingqun LuoDepartment of Clinical Medicine, College of Integrated Traditional Chinese and Western Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350004, China.
Kesheng WangDepartment of Biostatistics and Epidemiology, College of Public Health, East Tennessee State University, Johnson City, TN 37614, USA.
Juncao HuangBiological Psychiatry Research Center, Beijing Huilongguan Hospital, Beijing 100096, China.
Ting XieBiological Psychiatry Research Center, Beijing Huilongguan Hospital, Beijing 100096, China.
Chengchou ZhengMinqing Psychiatric Hospital, Minqing, Fujian 350800, China.
Kebing YangBiological Psychiatry Research Center, Beijing Huilongguan Hospital, Beijing 100096, China.
Jinghui TongBiological Psychiatry Research Center, Beijing Huilongguan Hospital, Beijing 100096, China.
Lingjun ZuoDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA.
Longli KangKey Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Diseases of Tibet Autonomous Region, Xizang Minzu University School of Medicine, Xiangyang, Shaanxi 712082, China.
Yunlong TanBiological Psychiatry Research Center, Beijing Huilongguan Hospital, Beijing 100096, China.
Kaida JiangShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Chiang-Shan R LiDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA.
Xingguang LuoDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA.
Beijing HuiLongGuan Hospital · CNYale University · USShanghai Mental Health Center · CNEast Tennessee State University · USUniversity of Tennessee Health Science Center · US

Funding

A noradrenergic mechanism of apathy and motivation deficit in MCI and ADR21AG067024 · NIA · YALE UNIVERSITY · PI LI, CHIANG-SHAN RAY · 2020 to 2020
$404k
Sequencing of glutamatergic pathway genes in alcohol and nicotine co-dependenceR21AA020319 · NIAAA · YALE UNIVERSITY · PI ZUO, LINGJUN · 2011 to 2012
$344k
Post-GWAS transcriptome-wide LncRNA expression profiling in alcohol dependenceR21AA023237 · NIAAA · YALE UNIVERSITY · PI LUO, XINGGUANG · 2015 to 2016
$344k
Deep sequencing of genes in ethanol-metabolism pathway in alcoholismR21AA021380 · NIAAA · YALE UNIVERSITY · PI LUO, XINGGUANG · 2014 to 2015
$339k
NIAAA NIH HHS R21 AA020319NIAAA NIH HHS R21 AA021380NIAAA NIH HHS R21 AA023237NIA NIH HHS R21 AG067024
6 · The paper itself

Abstract

Genome-wide association studies (GWASs) have reported numerous associations between risk variants and major psychiatric disorders (MPDs) including schizophrenia (SCZ), bipolar disorder (BPD), major depressive disorder (MDD) and others. We reviewed all of the published GWASs, and extracted the genome-wide significant (p<10

Indexed as

bipolar disorder (BPD)CACNA1Cgenome-wide association study (GWAS)major depressive disorder (MDD)major psychiatric disorders (MPD)schizophrenia (SCZ)

Identifiers

PMID34046650
PMCPMC8153461
OpenAlexW3142552932

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.